The Wire Retires: Software Matches FFR for Stenting
Key Takeaway: A large-scale international study has revealed that analyzing standard angiogram images with sophisticated computer analysis to evaluate borderline coronary blockages yields results identical to the traditional method of advancing a pressure-measuring wire into the artery. This less invasive approach could enable faster, safer, and more widespread adoption of rational stent decisions globally.
A Critical Heart Procedure, Simplified
Imagine for a moment being in the catheterization lab, where your cardiologist is examining a blockage on a screen via a thin tube running to your coronary arteries. Now, imagine being told that to decide if you truly need a stent, a special wire must be passed through that very blockage. This extra step not only adds to the procedure time and cost but also carries a small but real risk of complications. For decades, this pressure-wire measurement, known as fractional flow reserve (FFR), has been the gold standard. But what if the images already on the screen contained all the information needed to make this vital decision? A major recently published study shows this is precisely the case, and the implications could be enormous.
It is important to note a key point here. Another group published a study of a similar nature in the July issue of the NEJM[6]. At Vitalsdaily, we aimed to evaluate the findings from both of these studies and present them to our readers.
Why Measuring Blood Flow Is Critical
Not every blockage in a coronary artery requires a stent. A narrowing that appears dramatic on an angiogram might not be sufficiently restricting blood flow to the heart muscle, while a less severe-looking lesion can sometimes pose a serious obstruction. In the 1990s, researchers developed FFR, a technique where a hair-thin wire with a pressure sensor at its tip is passed beyond the stenosis to measure the pressure drop across it[2]. If the ratio of the pressure distal to the blockage to the pressure proximal to it falls below a certain threshold (typically 0.80), the stenosis is considered hemodynamically significant, and stenting is recommended. Landmark trials like FAME and FAME 2 proved that using FFR to guide stent decisions reduces heart attacks and unnecessary procedures compared to visual assessment alone[3].
The problem? Measuring FFR with a pressure wire requires an additional device, extends the procedure time, necessitates the use of drugs like adenosine to maximally dilate the vessels, and carries a small risk of vessel injury. Consequently, despite guideline recommendations, FFR is used in only a small fraction of cases worldwide[4]. The technology to do better existed; now, the scientific evidence supports it.
The Study’s Design
An international research team conducted a randomized, non-inferiority trial involving 1,930 patients with intermediate coronary stenoses. These were lesions significant enough to warrant further evaluation but where stenting was not an obvious choice. Patients were randomly assigned to two groups: In the first group, the stent decision was guided by angiography-derived FFR (FFRangio), a method that calculates the pressure drop from the standard X-ray images already taken. In the second group, the decision was guided by the traditional pressure-wire FFR measurement. The primary endpoint was a composite of death, heart attack, or any unplanned repeat procedure within one year.
What the Study Found
The results were remarkable in their equivalence. The rate of the primary endpoint was 6.9% in the FFRangio group compared to 7.1% in the pressure-wire group. This difference was clinically insignificant[1]. Statistical analysis confirmed non-inferiority with high confidence (P<0.001). Equally important, there was no difference in procedure-related adverse events between the two strategies, reinforcing that the image-based approach introduced no new safety concerns.
How the Technology Works
FFRangio belongs to a family of computational techniques that create a three-dimensional model of the coronary artery from two or more standard angiographic projections. The software then simulates blood flow through the reconstructed vessel, using the principles of computational fluid dynamics—the same physics engineers use to model airflow over an airplane wing—to calculate the expected pressure drop across the stenosis[5]. This entire analysis can be completed in minutes while the patient is still on the table, without any additional wires, catheters, or drugs.
The biological rationale for this approach is straightforward. A coronary stenosis creates resistance to flow. As blood accelerates through the narrowed segment, its kinetic energy increases at the expense of pressure energy, a relationship described by Bernoulli’s principle. While traditional FFR directly measures this pressure loss, FFRangio calculates it from the vessel geometry captured on the angiogram. The study’s results demonstrate that this computational estimate is accurate enough to guide clinical decisions with equivalent confidence.
Why These Findings Matter for the Future
The potential implications of this finding extend far beyond practical convenience. In many hospitals worldwide, particularly in resource-limited regions, pressure wires are either unavailable or prohibitively expensive. A software-based solution that works from already-acquired images could elevate physiological stenosis assessment to a universal standard on a global scale. This would allow more patients to benefit from an evidence-based evaluation of their blockages, leading to fewer unnecessary stents. Indeed, stenting a lesion that does not restrict flow offers no advantage over medical therapy alone[3].
For patients, the practical meaning carries a reassuring potential: your cardiologist can now make the same high-quality decision about whether you need a stent without the extra step of an invasive wire. The procedure becomes shorter, potentially less costly, and marginally safer, all while preserving the same excellent outcomes.
Key Limitations
No single study, however large, is sufficient for generalization on such an important topic. The study’s follow-up period was one year; longer-term data will be essential to confirm that outcomes remain equivalent over time. The study included patients with intermediate stenoses, and the results may not apply to those with highly complex anatomy, extremely calcified vessels, or multiple severe blockages. Additionally, the computational algorithms require high-quality angiographic images; suboptimal imaging could reduce accuracy. Finally, while the study proved non-inferiority, it was not designed to show superiority; the two strategies performed equally, and this equality is itself a victory.
The Final Verdict
These two prestigious studies (ALL-RISE and FAST III), published concurrently in the New England Journal of Medicine (NEJM) and covered in another Vitalsdaily article, open the door to a new era in the assessment of intermediate coronary stenoses. While the traditional, invasive method of pressure-wire (FFR)-based physiological assessment has not seen widespread adoption due to operational challenges despite its clinical success, these studies have focused on wire-free digital modeling methods (FFRangio and vFFR) based solely on angiographic images. Presenting data from nearly 4,000 patients combined, both studies have proven that angiography-based physiological assessment is definitively non-inferior to the classic pressure wire in reducing death, heart attack, and repeat revascularization procedures at 1-year follow-up. These findings demonstrate that digital angiography technologies—which are less invasive, have a lower risk of complications, reduce the need for contrast and hyperemic agents, and streamline the procedure—can safely replace wire-based strategies in the catheterization lab.
For a generation of interventional cardiologists trained to reflexively reach for a pressure wire when they see a borderline lesion, these studies may be considered a watershed moment. The data strongly suggest that the computational analysis of standard angiographic images provides the same actionable information as an invasive measurement, with identical one-year patient outcomes. As this technology matures and integrates into cath lab workflows, it holds the potential to make rational stent decisions the standard, not the exception, bringing physiological assessment to every patient who needs it, anywhere in the world. This is not just an incremental improvement but a potential fundamental paradigm shift in how we treat hearts. Furthermore, the information gleaned from these studies will become even more valuable with the publication of long-term outcomes.
Scientific Sources
- Fearon WF, et al. Angiography-Derived Fractional Flow Reserve to Guide PCI. The New England journal of medicine. 2026;395(1):9-19. PubMed: https://pubmed.ncbi.nlm.nih.gov/41910384/
- Pijls NH, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996. PMID: 8637515
- Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009. PMID: 19144937
- Toth GG, et al. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J. 2014. PMID: 24644308
- Morris PD, et al. Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions. JACC Cardiovasc Interv. 2013. PMID: 23428006
- Daemen J, et. al.Angiography-Based Physiology to Guide Coronary Revascularization. N Engl J Med. 2026. PMID: 41910382
Medically reviewed by
Dr. Şekip Altunkan
Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."